# Liquid Biopsy Literature

## Reviews

1. Schwarzenbach, H., Hoon, D. S. B., & Pantel, K. (2011). Cell-free nucleic acids as biomarkers in cancer patients. Nature Reviews Cancer, 11(6), 426–437. http://doi.org/10.1038/nrc3066

2. Alix-Panabieres, C., & Pantel, K. (2013). Circulating Tumor Cells: Liquid Biopsy of Cancer. Clinical Chemistry, 59(1), 110–118. http://doi.org/10.1373/clinchem.2012.194258

3. Pantel, K., & Alix-Panabieres, C. (2013). Real-time Liquid Biopsy in Cancer Patients: Fact or Fiction? Cancer Research, 73(21), 6384–6388. http://doi.org/10.1158/0008-5472.CAN-13-2030

4. Crowley, E., Di Nicolantonio, F., Loupakis, F., & Bardelli, A. (2013). Liquid biopsy: monitoring cancer-genetics in the blood. Nature Reviews Clinical Oncology, 10(8), 472–484. http://doi.org/10.1038/nrclinonc.2013.110

5. Heitzer, E., Ulz, P., & Geigl, J. B. (2015). Circulating Tumor DNA as a Liquid Biopsy for Cancer. Clinical Chemistry, 61(1), 112–123. http://doi.org/10.1373/clinchem.2014.222679

6. Pantel, K., & Alix-Panabières, C. (2017). Liquid biopsy in 2016: Circulating tumour cells and cell-free DNA in gastrointestinal cancer. Nature Reviews Gastroenterology & Hepatology, 14(2), 73–74. http://doi.org/10.1038/nrgastro.2016.198

7. Bardelli, A., & Pantel, K. (2017). Liquid Biopsies, What We Do Not Know (Yet). Cancer Cell, 31(2), 172–179. http://doi.org/10.1016/j.ccell.2017.01.002

8. Butler, T. M., Spellman, P. T., & Gray, J. (2017). Circulating-tumor DNA as an early detection and diagnostic tool. Current Opinion in Genetics and Development, 42, 14–21. http://doi.org/10.1016/j.gde.2016.12.003

9. Calapre, L., Warburton, L., Millward, M., Ziman, M., & Gray, E. S. (2017). Circulating tumour DNA (ctDNA) as a liquid biopsy for melanoma. Cancer Letters, 404, 62–69. http://doi.org/10.1016/j.canlet.2017.06.030

10. Cai, X., Janku, F., Zhan, Q., & Fan, J. B. (2015). Accessing Genetic Information with Liquid Biopsies. Trends in Genetics, 31(10), 564–575. http://doi.org/10.1016/j.tig.2015.06.001



## New Methods

1. Kinugasa, H., Nouso, K., Miyahara, K., Morimoto, Y., Dohi, C., Tsutsumi, K., … Yamamoto, K. (2015). Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer. Cancer, 121(13), 2271–2280. http://doi.org/10.1002/cncr.29364

2. Parisi, C., Mastoraki, S., Markou, A., Strati, A., Chimonidou, M., Georgoulias, V., & Lianidou, E. S. (2016). Development and validation of a multiplex methylation specific PCR-coupled liquid bead array for liquid biopsy analysis. Clinica Chimica Acta, 461, 156–164. http://doi.org/10.1016/j.cca.2016.08.003

3. Chung, T. K. H., Cheung, T. H., Yim, S. F., Yu, M. Y., Chiu, R. W. K., Lo, K. W. K., … Wong, Y. F. (2017). Liquid biopsy of PIK3CA mutations in cervical cancer in Hong Kong Chinese women. Gynecologic Oncology, 146(2), 334–339. http://doi.org/10.1016/j.ygyno.2017.05.038

4. Pel, J., Choi, W. W. Y., Leung, A. O., Shibahara, G., Gelinas, L., Despotovic, M., … Marziali, A. (2017). Duplex Proximity Sequencing (Pro-Seq): A method to improve DNA sequencing accuracy without the cost of molecular barcoding redundancy. bioRxiv. http://doi.org/10.1101/163444

5. Toledo, R. A., Garralda, E., Mitsi, M., Pons, T., Monsech, J., Vega, E., … Hidalgo, M. (2017). Whole-exome sequencing of plasma cell-free DNA portrays the somatic mutation landscape of refractory metastatic colorectal cancer and enables the discovery of mutated KDR/VEGFR2 receptors as modulators of anti-angiogenic therapies. bioRxiv, 177287. http://doi.org/10.1101/177287

6. Sorber, L., Zwaenepoel, K., Deschoolmeester, V., Van Schil, P. E. Y., Van Meerbeeck, J., Lardon, F., … Pauwels, P. (2017). Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients. Lung Cancer, 107, 100–107. http://doi.org/10.1016/j.lungcan.2016.04.026

7. Cohen, J. D., Javed, A. A., Thoburn, C., Wong, F., Tie, J., Gibbs, P., … Lennon, A. M. (2017). Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers. Proceedings of the National Academy of Sciences of the United States of America, 114(38), 10202–10207. http://doi.org/10.1073/pnas.1704961114

8. Alcaide, M., Yu, S., Davidson, J., Albuquerque, M., Bushell, K., Fornika, D., … Morin, R. D. (2017). Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baits. Scientific Reports, (August), 1–19. http://doi.org/10.1038/s41598-017-10269-2


